Cargando…
Tissue-agnostic cancer drugs in the fight against molecular subsets of metastases of unknown origin
Autores principales: | Roncati, Luca, Palmieri, Beniamino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855365/ https://www.ncbi.nlm.nih.gov/pubmed/31763371 http://dx.doi.org/10.18632/oncoscience.492 |
Ejemplares similares
-
What about the original antigenic sin of the humans versus SARS-CoV-2?
por: Roncati, Luca, et al.
Publicado: (2020) -
Drug Development in Tissue-Agnostic Indications
por: du Rusquec, Pauline, et al.
Publicado: (2021) -
The Standard Output: A Tool‐Agnostic Modeling Storage Format
por: Terranova, Nadia, et al.
Publicado: (2018) -
Treatable Subsets in Cancer of Unknown Primary Origin
por: Sumi, Hajime, et al.
Publicado: (2001) -
Severe acute hepatitis of unknown origin in children: Clinical issues of concern
por: Fu, Hai-Jing, et al.
Publicado: (2023)